{"id":"tranexamic-acid-standard-of-care","safety":{"commonSideEffects":[{"rate":null,"effect":"Thromboembolic events (deep vein thrombosis, pulmonary embolism)"},{"rate":null,"effect":"Seizures"},{"rate":null,"effect":"Visual disturbances"},{"rate":null,"effect":"Gastrointestinal disturbances"},{"rate":null,"effect":"Hypotension"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Tranexamic acid is an antifibrinolytic agent that competitively inhibits the conversion of plasminogen to plasmin, thereby preventing the breakdown of fibrin clots. By stabilizing clot formation, it reduces excessive bleeding in perioperative and acute hemorrhage contexts. When used as an adjunct to standard of care protocols, it decreases transfusion requirements and improves hemostatic outcomes.","oneSentence":"Tranexamic acid inhibits fibrinolysis by blocking plasminogen activation, reducing blood loss in surgical and trauma settings when combined with standard care.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:13:45.528Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Reduction of blood loss in surgical procedures"},{"name":"Treatment of acute hemorrhage in trauma"},{"name":"Prevention of excessive bleeding in perioperative settings"}]},"trialDetails":[{"nctId":"NCT07033039","phase":"NA","title":"Effects of Red and Infrared Photobiomodulation in Rhinoplasty at a Single Centre","status":"RECRUITING","sponsor":"University of Nove de Julho","startDate":"2026-01-30","conditions":"Rhinoplasty, Edema","enrollment":60},{"nctId":"NCT03128866","phase":"EARLY_PHASE1","title":"Tranexamic Acid in Reducing Blood Loss in Patients With Pelvic Tumors Undergoing Hemipelvectomy Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2017-05-19","conditions":"Pelvic Mass","enrollment":80},{"nctId":"NCT07115056","phase":"PHASE4","title":"Extended Oral Tranexamic Acid After Anterior Cruciate Ligament Reconstruction","status":"WITHDRAWN","sponsor":"Campbell Clinic","startDate":"2026-04-01","conditions":"ACL Injury, ACL Tears, ACL Surgery","enrollment":""},{"nctId":"NCT07434453","phase":"NA","title":"\"Topical Tranexamic Acid With Flap Fixation: A Novel Approach to Minimize Post-operative Drainage and Surgical Site Infection in Patients Undergoing Modified Radical Mastectomy\"","status":"COMPLETED","sponsor":"Noor ul Ain","startDate":"2023-08-04","conditions":"Breast Cancer Females","enrollment":62},{"nctId":"NCT07410130","phase":"","title":"Clinical Spectrum and Management of Von Willebrand Disease Among Children in Assiut Governorate","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-03","conditions":"Von Willebrand Disease (VWD), Inherited Bleeding Disorders in Children, Pediatric Hemostatic Disorders","enrollment":25},{"nctId":"NCT07362992","phase":"EARLY_PHASE1","title":"Topical Tranexamic Acid to Reduce Blood Loss During Cesarean Delivery","status":"NOT_YET_RECRUITING","sponsor":"Wolfson Medical Center","startDate":"2026-01-01","conditions":"Cesarean Delivery, Postpartum Hemorrhage (PPH), Intraoperative Blood Loss","enrollment":112},{"nctId":"NCT05836831","phase":"PHASE4","title":"Indian Trial of Tranexamic Acid in Spontaneous Intracerebral Haemorrhage","status":"RECRUITING","sponsor":"Christian Medical College and Hospital, Ludhiana, India","startDate":"2022-08-30","conditions":"Intracerebral Hemorrhagic Stroke","enrollment":3400},{"nctId":"NCT05053867","phase":"PHASE3","title":"A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2022-10-14","conditions":"Pulmonary Hemorrhage, Cancer","enrollment":60},{"nctId":"NCT05345613","phase":"PHASE4","title":"Tranexamic Acid During Colonic Endoscopic Resection Procedures","status":"RECRUITING","sponsor":"Assaf-Harofeh Medical Center","startDate":"2022-05-01","conditions":"Colon Neoplasm","enrollment":200},{"nctId":"NCT05075200","phase":"PHASE2","title":"Tranexamic Acid Dosing for Major Joint Replacement Surgery","status":"COMPLETED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2021-12-14","conditions":"Arthroplasty, Replacement, Knee, Arthroplasty, Replacement, Hip","enrollment":21},{"nctId":"NCT07261930","phase":"PHASE4","title":"Effectiveness of Tranexamic Acid in Reducing Blood Loss During Femoral Nail Surgery","status":"COMPLETED","sponsor":"Masaka Regional Referral Hospital","startDate":"2018-10-01","conditions":"Femoral Fractures, Hemorrhage, Surgical, Tranexamic Acid Use","enrollment":43},{"nctId":"NCT05441592","phase":"PHASE4","title":"A Randomized Control Trial Assessing the Effect of Topical Tranexamic Acid on Risk of Hematoma in Breast Surgery","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2022-08-15","conditions":"Hematoma Postoperative","enrollment":107},{"nctId":"NCT04811313","phase":"NA","title":"Tranexamic Acid in Pediatric Undergoing Proximal Femoral Osteotomies and/or Acetabular Osteotomy","status":"RECRUITING","sponsor":"Assiut University","startDate":"2025-04-03","conditions":"Intraoperative Blood Loss, Pediatric, Orthopedic Disorder","enrollment":400},{"nctId":"NCT05794321","phase":"PHASE2","title":"Investigating the Use of Intravenous Tranexamic Acid in Gender Affirming Mastectomy","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2023-09-28","conditions":"Postoperative Hematoma, Postoperative Seroma","enrollment":150},{"nctId":"NCT06057675","phase":"PHASE2","title":"Tranexamic Acid in Nasal Mohs Reconstruction","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2024-03-19","conditions":"Postoperative Bleeding, Skin Cancer Face","enrollment":100},{"nctId":"NCT06208267","phase":"NA","title":"Tranexamic Acid Use on Pain, Mobility and Bleeding Following Total Hip and Total Knee Arthroplasty","status":"RECRUITING","sponsor":"St. Mary's Research Center, Canada","startDate":"2025-08-20","conditions":"Postoperative Bleeding","enrollment":210},{"nctId":"NCT05713630","phase":"PHASE3","title":"The Use of Tranexamic Acid in the Treatment of Symptomatic Subdural Hematoma","status":"NOT_YET_RECRUITING","sponsor":"Unity Health Toronto","startDate":"2025-09-30","conditions":"Subdural Hematoma","enrollment":130},{"nctId":"NCT03598907","phase":"","title":"Point-of-care Management of Coagulopathy in Lung Transplantation","status":"TERMINATED","sponsor":"University Hospital, Motol","startDate":"2018-01-01","conditions":"Lung Transplantation","enrollment":100},{"nctId":"NCT06128330","phase":"PHASE4","title":"Point-of-care Measurement of the Antifibrinolytic Activity of Tranexamic Acid in Cardiac Surgery","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2023-12-15","conditions":"Antifibrinolytic Agents","enrollment":322},{"nctId":"NCT07005661","phase":"PHASE2, PHASE3","title":"Use of PRP in Open Surgery for Type A Aortic Dissection","status":"NOT_YET_RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2025-06-30","conditions":"Aortic Dissection Type A, Transfusions, Platelet Rich Plasma (PRP)","enrollment":250},{"nctId":"NCT06657924","phase":"PHASE2","title":"Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery","status":"RECRUITING","sponsor":"Kristen Ban","startDate":"2025-02-11","conditions":"Bleeding, Colorectal Disorders, Thromboembolism","enrollment":394},{"nctId":"NCT04625530","phase":"PHASE3","title":"Perioperative Management in Gynaecological Carcinoma Surgery","status":"WITHDRAWN","sponsor":"University Hospital, Basel, Switzerland","startDate":"2021-08-01","conditions":"Gynaecological Carcinoma","enrollment":""},{"nctId":"NCT06384456","phase":"PHASE4","title":"Topical TRanexamic Acid Vs. Placebo on Acute Postoperative Pain Following DRF Fixation","status":"NOT_YET_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2025-03","conditions":"Distal Radius Fractures","enrollment":90},{"nctId":"NCT04278404","phase":"","title":"Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)","status":"RECRUITING","sponsor":"Duke University","startDate":"2020-03-05","conditions":"Coronavirus Infection (COVID-19), Pulmonary Arterial Hypertension, Urinary Tract Infections in Children","enrollment":5000},{"nctId":"NCT06781021","phase":"NA","title":"The Effect of Tranexamic Acid Vs Torniquet on Visual Clarity in Knee Arthroscopic ACL Reconstruction","status":"ENROLLING_BY_INVITATION","sponsor":"The University of The West Indies","startDate":"2024-11-01","conditions":"ACL Tears","enrollment":60},{"nctId":"NCT04272606","phase":"PHASE2","title":"TXA in Spinal Fusion","status":"COMPLETED","sponsor":"Catherine R. Olinger","startDate":"2020-08-01","conditions":"Degenerative Disc Disease","enrollment":123},{"nctId":"NCT06648369","phase":"NA","title":"Maximal Medical Treatment of Intracerebral Haemorrhage Pilot Trial - MAX-ICH Pilot Trial","status":"NOT_YET_RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2024-12-01","conditions":"Intra Cerebral Hemorrhage","enrollment":50},{"nctId":"NCT06622564","phase":"PHASE3","title":"Decreasing Postoperative Blood Loss and Seizures by Timing of Intravenous Tranexamic Acid 2 Pilot Trial","status":"NOT_YET_RECRUITING","sponsor":"Hamilton Health Sciences Corporation","startDate":"2025-01-01","conditions":"Bleeding, Surgical Blood Loss, Seizures","enrollment":40},{"nctId":"NCT06509256","phase":"EARLY_PHASE1","title":"Different Methods of Tranexamic Acid Application in Controlling Peri Operative Bleeding in Gynecomastia Surgery","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-07-20","conditions":"Pharmacological-Aggravated Urticaria","enrollment":50},{"nctId":"NCT03517098","phase":"NA","title":"Enhanced Recovery After Surgery (ERAS) Pathway for Primary Hip and Knee Arthroplasty","status":"COMPLETED","sponsor":"West China Hospital","startDate":"2021-02-01","conditions":"Arthroplasty, Replacement, Hip, Knee","enrollment":640},{"nctId":"NCT03780894","phase":"PHASE1, PHASE2","title":"Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage at Pre-hospital Phase of Care.","status":"COMPLETED","sponsor":"Banc de Sang i Teixits","startDate":"2018-11-21","conditions":"Polytrauma, Traumatic Hemorrhage","enrollment":79},{"nctId":"NCT05382403","phase":"NA","title":"Novel Vacuum-Induced Hemorrhage Control for Postpartum Hemorrhage","status":"RECRUITING","sponsor":"Women and Infants Hospital of Rhode Island","startDate":"2023-10-23","conditions":"Postpartum Hemorrhage, Maternal Death","enrollment":424},{"nctId":"NCT04149171","phase":"PHASE3","title":"Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage","status":"COMPLETED","sponsor":"Cristina Martinez","startDate":"2018-09-26","conditions":"Hemorrhagic Shock","enrollment":30},{"nctId":"NCT05672407","phase":"PHASE4","title":"The Role of Local Tranexamic Acid on Periorbital Oculoplastic Surgery","status":"WITHDRAWN","sponsor":"University of Miami","startDate":"2023-09-01","conditions":"Eyelid Diseases, Periorbital Disorder, Hemorrhage","enrollment":""},{"nctId":"NCT01431326","phase":"","title":"Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care","status":"COMPLETED","sponsor":"Daniel Benjamin","startDate":"2011-11","conditions":"Adenovirus, Anesthesia, Anxiety","enrollment":3520},{"nctId":"NCT05639686","phase":"NA","title":"TIVA vs TXA in Sinus Surgery to Evaluate Operative Blood Loss and Surgical Field Quality","status":"UNKNOWN","sponsor":"Our Lady of the Lake Hospital","startDate":"2023-01-01","conditions":"Rhinosinusitis Chronic, Sinus Cancer, Sinus Polyp","enrollment":100},{"nctId":"NCT01869413","phase":"PHASE2, PHASE3","title":"Tranexamic Acid During Cystectomy Trial (TACT)","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2013-06","conditions":"Bladder Cancer","enrollment":354},{"nctId":"NCT02053363","phase":"PHASE2, PHASE3","title":"Tranexamic Acid Dosing in Adult Spinal Deformity Surgery","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2014-03","conditions":"Adult Spinal Deformity","enrollment":64},{"nctId":"NCT03690037","phase":"PHASE4","title":"Investigating the Effect of Intravenous and Oral Tranexamic Acid on Blood Loss After Primary Hip and Knee Arthroplasty","status":"COMPLETED","sponsor":"Belfast Health and Social Care Trust","startDate":"2016-07-07","conditions":"Primary Total Knee Arthroplasty, Primary Total Hip Arthroplasty","enrollment":1089},{"nctId":"NCT04804345","phase":"","title":"AProtinin Versus Tranexamic Acid in Cardiac Surgery Patients With High-risk for Excessive Bleeding","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2021-03-31","conditions":"Cardiac Surgery, Cardiopulmonary Bypass, High Risk Bleeding","enrollment":693},{"nctId":"NCT04907812","phase":"PHASE4","title":"The Role of Tranexamic Acid in Reducing Post Operative Hand Edema After Hand and Wrist Surgery","status":"UNKNOWN","sponsor":"Ruby Grewal","startDate":"2021-06-01","conditions":"Hand Injuries and Disorders, Distal Radius Fracture, Dupuytren Contracture","enrollment":50},{"nctId":"NCT04788121","phase":"PHASE3","title":"Efficacy of Tranexamic Acid in Upper Gastrointestinal Bleeding","status":"UNKNOWN","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2020-11-01","conditions":"Gastro Intestinal Bleeding","enrollment":160},{"nctId":"NCT02684812","phase":"PHASE2, PHASE3","title":"Ultra-early Tranexamic Acid After Subarachnoid Hemorrhage.","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2012-07-16","conditions":"Subarachnoid Hemorrhage","enrollment":955},{"nctId":"NCT02026297","phase":"PHASE2","title":"Tranexamic Acid and Thromboelastography During Cesarean Delivery","status":"TERMINATED","sponsor":"Brigham and Women's Hospital","startDate":"2014-07","conditions":"Postpartum Hemorrhage","enrollment":60},{"nctId":"NCT02655653","phase":"PHASE3","title":"Efficacy of Tranexamic Acid and Epsilon-aminocaproic Acid in Reducing Bleeding and Transfusions in Cardiac Surgery","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"2008-10","conditions":"Bleeding","enrollment":114},{"nctId":"NCT02278263","phase":"PHASE4","title":"Tranexamic Acid in Knee Joint Surgery","status":"COMPLETED","sponsor":"Andrew G Hill, MBChB, MD (Thesis), EdD, FACS, FRACS","startDate":"2014-12","conditions":"Osteoarthritis","enrollment":150},{"nctId":"NCT01940523","phase":"PHASE4","title":"Randomized Controlled Trial of Tranexamic Acid in Total Knee Arthroplasty: Intravenous vs. Topical","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2013-05","conditions":"Osteoarthritis","enrollment":640},{"nctId":"NCT03888768","phase":"NA","title":"ProPBM : A Modified Patient Blood Management Protocol","status":"UNKNOWN","sponsor":"Ministry of Health, Malaysia","startDate":"2019-08-01","conditions":"Iron-deficiency","enrollment":180},{"nctId":"NCT02030821","phase":"PHASE4","title":"TXA vs. Amicar in Total Knee and Hip Arthroplasty","status":"COMPLETED","sponsor":"Duke University","startDate":"2015-01","conditions":"Blood Loss, Hip Arthritis, Knee Arthritis","enrollment":246},{"nctId":"NCT03509168","phase":"PHASE2, PHASE3","title":"The Efficacy and Safety of Preoperative Misoprostol in Blood-loss Reduction During Myomectomy.","status":"UNKNOWN","sponsor":"Makerere University","startDate":"2018-01-10","conditions":"Uterine Fibroid","enrollment":46},{"nctId":"NCT02579941","phase":"NA","title":"Evaluation of the Minimum Concentration of Tranexamic Acid Required to Inhibit Fibrinolysis in a Population of Pregnant Women at Term.","status":"COMPLETED","sponsor":"Brugmann University Hospital","startDate":"2015-11","conditions":"Hyperfibrinolysis","enrollment":40},{"nctId":"NCT02648295","phase":"","title":"Effects of IV Tranexamic Acid on the Thromboelastogram in Patients Undergoing Total Hip or Knee Arthroplasty","status":"COMPLETED","sponsor":"West Virginia University","startDate":"2015-12","conditions":"Status Post Total Hip and Knee Arthroplasty","enrollment":60},{"nctId":"NCT01651182","phase":"PHASE3","title":"Tranexamic Acid Versus Placebo for Blood to Reduce Perioperative Bleeding Post-liver Resection","status":"COMPLETED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2014-03","conditions":"Cancer, Tumour, Surgery","enrollment":24},{"nctId":"NCT01895101","phase":"PHASE4","title":"The Effect on Blood Loss of Topical and Intravenous Tranexamic Acid in Cardiac Surgery Patients","status":"COMPLETED","sponsor":"Amphia Hospital","startDate":"2013-10","conditions":"Blood Loss, Tranexamic Acid, Cardiac Surgery","enrollment":750},{"nctId":"NCT02071316","phase":"NA","title":"The Use of Hexacapron in Upper Gastrointestinal Bleeding","status":"UNKNOWN","sponsor":"Shaare Zedek Medical Center","startDate":"2014-04","conditions":"Upper Gastrointestinal Bleeding, Hexacapron, Hemostasis","enrollment":300},{"nctId":"NCT01655641","phase":"PHASE2, PHASE3","title":"Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery","status":"UNKNOWN","sponsor":"Tribhuvan University Teaching Hospital, Institute Of Medicine.","startDate":"2012-07","conditions":"Gastric Cancer, Pancreatic Cancer, Hepatocellular Cancer","enrollment":118},{"nctId":"NCT00827931","phase":"PHASE4","title":"Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Major Abdominal Surgery","status":"COMPLETED","sponsor":"Pfizer","startDate":"2009-09","conditions":"Biliary Tract Surgical Procedures, Pancreaticoduodenectomy, Esophagectomy","enrollment":94},{"nctId":"NCT01260818","phase":"NA","title":"Topical Application of Tranexamic Acid Reduces Postoperative Blood Loss in Total Hip Arthroplasty","status":"UNKNOWN","sponsor":"The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine","startDate":"2010-12","conditions":"Hip Replacement, Postoperative Hemorrhage","enrollment":100},{"nctId":"NCT00824564","phase":"PHASE4","title":"Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Surgery For Long Bone Fracture","status":"COMPLETED","sponsor":"Pfizer","startDate":"2009-04","conditions":"Femoral Fractures","enrollment":82}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":51,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Tranexamic acid + Standard of Care","genericName":"Tranexamic acid + Standard of Care","companyName":"Pfizer","companyId":"pfizer","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tranexamic acid inhibits fibrinolysis by blocking plasminogen activation, reducing blood loss in surgical and trauma settings when combined with standard care. Used for Reduction of blood loss in surgical procedures, Treatment of acute hemorrhage in trauma, Prevention of excessive bleeding in perioperative settings.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}